Medicine
Doxorubicin 2 mg/mL powder for injection
Doxorubicin 2 mg/mL powder for injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store all vials at 20° to 25°C (68° to 77°F). Protect from light. The…
Key facts
- Active ingredient (INN)
- Doxorubicin
- Brand
- Sold under the generic name
- Strength
- 2 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 cartons, 1 vial and 2 more
- Manufacturers
- Amneal PharmaceuticalsHikma PharmaceuticalsMylan Institutional
- Origin register
- US FDA, United States
- Storage
- Store all vials at 20° to 25°C (68° to 77°F). Protect from light. The reconstituted solution is stable for 7 days at room temperature and under normal room light (100 foot-candles) and 15 days under refrigeration (2° to 8°C). It should be protected from exposure to sunlight.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01DB01 Doxorubicin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 February 2014
- Identifiers
- RxCUI 1790095, 1790103, 1872062DailyMed set ID f62aa88d-1e25-4049-87ec-99d42edd1d31, 5f71f79a-4f14-472d-b982-e28c3ce8f972, d928625e-c1ef-4f25-8d25-764c8c6aab67NDC 0143-9093, 67457-436, 70121-1218 +2Application ANDA062921, ANDA200170, ANDA208888
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 carton in 1 carton / 1 vial in 1 carton / 10 mL in 1 vial | 70121-1218-7 | Amneal Pharmaceuticals | 17 February 2017 |
| 1 vial in 1 carton / 25 mL in 1 vial | 70121-1219-1 | Amneal Pharmaceuticals | 17 February 2017 |
| 1 vial in 1 box / 5 mL in 1 vial | 0143-9092-01 | Hikma Pharmaceuticals | 19 January 2018 |
| 1 vial in 1 box / 25 mL in 1 vial | 0143-9093-01 | Hikma Pharmaceuticals | 19 January 2018 |
| 1 vial in 1 carton / 25 mL in 1 vial | 67457-436-50 | Mylan Institutional | 27 February 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Doxorubicin
Clinical summary
Doxorubicin is an anthracycline topoisomerase inhibitor indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer, among other approved uses. MedsAcross supplies Doxorubicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxorubicinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxorubicin Hydrochloride prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
- Caelyx pegylated liposomal: European public assessment report (EPAR) · European Medicines Agency
- Myocet liposomal (previously Myocet): European public assessment report (EPAR) · European Medicines Agency
Need Doxorubicin 2 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.